Stay updated on Onasemnogene for SMA: Intrathecal Clinical Trial
Sign up to get notified when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.

Latest updates to the Onasemnogene for SMA: Intrathecal Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1), indicating a new release. The Back to Top element was removed, which is a minor UI change.SummaryDifference0.1%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has updated its facility name and location details, specifically emphasizing St. Louis, Missouri, and the addition of Zolgensma, a treatment for proximal spinal muscular atrophy.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.7%
Stay in the know with updates to Onasemnogene for SMA: Intrathecal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.